Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
1997-4-28
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0098-7484
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1182, 1184
|
pubmed:dateRevised |
2006-11-7
|
pubmed:meshHeading |
pubmed-meshheading:9103328-Disability Evaluation,
pubmed-meshheading:9103328-Drug Therapy, Combination,
pubmed-meshheading:9103328-Employment,
pubmed-meshheading:9103328-HIV Infections,
pubmed-meshheading:9103328-HIV Protease Inhibitors,
pubmed-meshheading:9103328-Humans,
pubmed-meshheading:9103328-Sick Leave
|
pubmed:year |
1997
|
pubmed:articleTitle |
Protease inhibitors bring new social, clinical uncertainties to HIV care.
|
pubmed:publicationType |
News
|